Upstream Bio, Inc. (UPB)
Nasdaq: UPB · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2024
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 26, 2026 | Mar 12, 2025 | · |
| Revenue | 2,854 | 2,370 | 2,380 |
| Research and development | 136,806 | 62,966 | 31,799 |
| General and administrative | 26,409 | 17,168 | 10,695 |
| Total operating expenses | 163,215 | 80,134 | 42,494 |
| Operating income | -160,361 | -77,764 | -40,114 |
| Interest and investment income | 16,933 | 12,123 | 4,165 |
| Interest income (expense), net | 16,900 | 12,100 | 4,200 |
| Total non-operating income (expense) | 16,918 | 14,958 | 19,577 |
| Income tax expense | 0 | 0 | 0 |
| Net income including non-controlling interests | -143,443 | -62,806 | -20,537 |
| Net income | -143,443 | -62,806 | -20,537 |
| Net income to common shareholders | -143,443 | -76,395 | -38,255 |
| Earnings per share, basic | -2.66 | -5.58 | -12.95 |
| Earnings per share, diluted | -2.66 | -5.58 | -12.95 |
| Weighted average shares, basic | 53,852,752 | 13,682,326 | 2,953,756 |
| Weighted average shares, diluted | 53,852,752 | 13,682,326 | 2,953,756 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding